
Phi Hoang
Examiner (ID: 1921, Phone: (571)270-3417 , Office: P/2613 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2678, 2619, 2628, 2613, 4178 |
| Total Applications | 1057 |
| Issued Applications | 820 |
| Pending Applications | 71 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13276523
[patent_doc_number] => 10149827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
[patent_app_type] => utility
[patent_app_number] => 15/946950
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4506
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946950 | Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies | Apr 5, 2018 | Issued |
Array
(
[id] => 14420055
[patent_doc_number] => 10314813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Antimicrobial compositions for
[patent_app_type] => utility
[patent_app_number] => 15/946070
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7767
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946070
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946070 | Antimicrobial compositions for | Apr 4, 2018 | Issued |
Array
(
[id] => 13338231
[patent_doc_number] => 20180220655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => FUNGICIDAL OR BACTERICIDAL COMPOSITION, AND METHOD FOR CONTROLLING DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/945786
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945786
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945786 | Fungicidal or bactericidal composition, and method for controlling diseases | Apr 4, 2018 | Issued |
Array
(
[id] => 13533403
[patent_doc_number] => 20180318244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 15/938837
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938837 | Modified release orally administered amino acid formulations | Mar 27, 2018 | Issued |
Array
(
[id] => 13944593
[patent_doc_number] => 10208052
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-02-19
[patent_title] => Compositions for activating pyruvate kinase
[patent_app_type] => utility
[patent_app_number] => 15/926236
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1406
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926236
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/926236 | Compositions for activating pyruvate kinase | Mar 19, 2018 | Issued |
Array
(
[id] => 13492793
[patent_doc_number] => 20180297939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/925559
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/925559 | Alpha-cinnamide compounds and compositions as HDAC8 inhibitors | Mar 18, 2018 | Issued |
Array
(
[id] => 13207003
[patent_doc_number] => 10117852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Glucocorticoid receptor modulators to treat pancreatic cancer
[patent_app_type] => utility
[patent_app_number] => 15/915477
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18077
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915477 | Glucocorticoid receptor modulators to treat pancreatic cancer | Mar 7, 2018 | Issued |
Array
(
[id] => 13424881
[patent_doc_number] => 20180263983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMBINATION OF CREATINE, AN OMEGA-3 FATTY ACID, AND CITICOLINE
[patent_app_type] => utility
[patent_app_number] => 15/916140
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15916140
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/916140 | Combination of creatine, an omega-3 fatty acid, and citicoline | Mar 7, 2018 | Issued |
Array
(
[id] => 16806028
[patent_doc_number] => 20210128581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHODS OF USE FOR TRP CHANNEL ANTAGONIST-BASED COMBINATION CANCER THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/491752
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491752 | Methods of use for TRP channel antagonist-based combination cancer therapies | Mar 4, 2018 | Issued |
Array
(
[id] => 17103527
[patent_doc_number] => 11123718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Oxovanadium phosphate catalyst, and preparation method and application therefor
[patent_app_type] => utility
[patent_app_number] => 16/961029
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6263
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961029 | Oxovanadium phosphate catalyst, and preparation method and application therefor | Feb 28, 2018 | Issued |
Array
(
[id] => 17095358
[patent_doc_number] => 20210283149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => COMPOSITIONS, METHODS, SYSTEMS AND/OR KITS FOR PREVENTING AND/OR TREATING NEOPLASMS
[patent_app_type] => utility
[patent_app_number] => 16/488565
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488565 | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | Feb 25, 2018 | Issued |
Array
(
[id] => 14005399
[patent_doc_number] => 10221135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => 1,4-substituted piperidine derivatives
[patent_app_type] => utility
[patent_app_number] => 15/903150
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99127
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15903150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/903150 | 1,4-substituted piperidine derivatives | Feb 22, 2018 | Issued |
Array
(
[id] => 13383457
[patent_doc_number] => 20180243270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => METHODS FOR TREATING CNS LESIONS
[patent_app_type] => utility
[patent_app_number] => 15/902316
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/902316 | Methods for treating CNS lesions | Feb 21, 2018 | Issued |
Array
(
[id] => 16663856
[patent_doc_number] => 10933078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
[patent_app_type] => utility
[patent_app_number] => 16/484179
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25278
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484179 | Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling | Feb 20, 2018 | Issued |
Array
(
[id] => 12837268
[patent_doc_number] => 20180170929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/899061
[patent_app_country] => US
[patent_app_date] => 2018-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 548
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899061
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/899061 | Pyrimidine-2,4-diamine derivatives for treatment of cancer | Feb 18, 2018 | Issued |
Array
(
[id] => 15524473
[patent_doc_number] => 20200054542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => OIL COMPOSITION, PRODUCTION METHOD THEREOF, OILY BASE AND EXTERNAL PREPARATION FOR SKIN
[patent_app_type] => utility
[patent_app_number] => 16/485820
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485820 | Oil composition, production method thereof, oily base and external preparation for skin | Feb 8, 2018 | Issued |
Array
(
[id] => 15537133
[patent_doc_number] => 10568324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Agricultural and horticultural material, and plant cultivation method which promote coloring in fruit
[patent_app_type] => utility
[patent_app_number] => 15/892825
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5371
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892825 | Agricultural and horticultural material, and plant cultivation method which promote coloring in fruit | Feb 8, 2018 | Issued |
Array
(
[id] => 16204677
[patent_doc_number] => 20200237667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => A BIODEGRADABLE NANO-THERANOSTIC COMPOSITE AND PROCESS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/483897
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483897
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483897 | Biodegradable nano-theranostic composite and process of preparation thereof | Feb 8, 2018 | Issued |
Array
(
[id] => 15206173
[patent_doc_number] => 20190365773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => SOLID DOSAGE FORM CONTAINING QUINAZOLINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/481552
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481552 | Solid dosage form containing quinazoline derivative | Jan 28, 2018 | Issued |
Array
(
[id] => 16412733
[patent_doc_number] => 10820589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Emulsifiable concentrate
[patent_app_type] => utility
[patent_app_number] => 16/480432
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5247
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480432 | Emulsifiable concentrate | Jan 22, 2018 | Issued |